[Skip to Navigation]
May 6, 2020

Association Between High-grade Myelodysplastic Syndrome and Cutaneous Langerhans Cell Histiocytosis Suggested by Next-Generation Sequencing

Author Affiliations
  • 1Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida
  • 2Department of Dermatology, Mayo Clinic, Jacksonville, Florida
  • 3Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
  • 4Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida
JAMA Dermatol. 2020;156(7):817-819. doi:10.1001/jamadermatol.2020.0544

Langerhans cell histiocytosis (LCH) is a rare dendritic cell disorder with variable cutaneous involvement. Recent evidence suggests that the LCH cell of origin is a myeloid precursor rather than a differentiated epidermal Langerhans cell.1 We report a case of clonally related cutaneous LCH preceded by myelodysplastic syndrome, in which a common clonal origin of these 2 disorders was suggested through next-generation sequencing.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words